LG
PPH icon

Leuthold Group’s VanEck Pharmaceutical ETF PPH Stock Holding History

Leuthold Group’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$776K Sell
7,097
-368
-5% -$38.1K 0.08% 169
2026
Q1 		$775K Sell
7,465
-1,314
-15% -$140K 0.08% 149
2025
Q4 		$906K Buy
+8,779
New +$854K 0.1% 139
2025
Q2 		– Sell
-4,303
Closed -$392K – 232
2025
Q1 		$392K Buy
+4,303
New +$388K 0.05% 172

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Leuthold Group's PPH Position: Q2 2026 in Review

Leuthold Group reduced its VanEck Pharmaceutical ETF (PPH) stake by 4.9% in Q2 2026, selling an estimated $38.1K and leaving 7,097 shares worth $776K. The position accounts for 0.08% of the portfolio, ranked #169.

Leuthold Group first reported a position in PPH in Q1 2025 and has held it in 4 quarters since. The position peaked at $906K in Q4 2025. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • Leuthold Group held 7,097 shares of VanEck Pharmaceutical ETF worth $776K as of Q2 2026.
  • Leuthold Group sold 368 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $38.1K.
  • VanEck Pharmaceutical ETF made up 0.08% of Leuthold Group's portfolio in Q2 2026, its #169 holding.
  • Leuthold Group first reported a position in VanEck Pharmaceutical ETF in Q1 2025 and has held it in 4 quarters since.
  • Leuthold Group's VanEck Pharmaceutical ETF position peaked at $906K in Q4 2025.
  • 148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Leuthold Group's 13F filing for Q2 2026, filed 4 Aug 2026.